TAKHZYRO® (lanadelumab) for Hereditary Angioedema Patients to be Presented at European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress
The Pharma Data
JULY 11, 2021
Hereditary angioedema is a lifelong condition and research shows that concerns about another attack can limit the way patients lead their lives,” said Prof. Department of Dermatology, Venereology and Allergology, Charité – Universitätsmedizin in Berlin, Germany. No dedicated drug-drug interaction studies have been conducted.
52 
Let's personalize your content